You have read all your free articles, to continue reading subscribe to read the rest of this content.
Devyser Diagnostics has announced its intention to launch an initial public offering of its shares and to list its shares on Nasdaq First North Premier Growth Market. The offering is expected to consist of both new shares issued by Devyser and of existing shares in the company. Nasdaq has announcAlready…
Immunovia has successfully completed its SEK 28.7 million rights issue of which the subscription period ended on Monday October 17th. The underwriters, who had guaranteed 52% of the rights issue, will thereby not be assigned any shares through their guarantee. 285,072 new shares, representing 86Already a subscriber Login You have read…
Umeå Biotech Incubator (UBI) aims to double the number of small and medium-sized life science companies operating in the Västerbotten county over the next ten years. “We have finally reached the incubator phase that I have been looking forward to for so long," said Jennie Ekbeck, CEO of UmeåAlready a…
The US Food and Drug Administration (FDA) has granted priority review for the company's New Drug Application seeking approval of melflufen in combination with dexamethasone for the treatment of adult patients with multiple myeloma whose disease is refractory to at least one proteasome inhibitor, oneAlready a subscriber Login You have…
